Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriers

Cortex

Volumn 57, Issue , 2014, Pages 167-176

  Li, Wenjun ^a   Antuono, Piero G ^a   Xie, Chunming ^a   Chen, Gang ^a   Jones, Jennifer L ^a   Ward, B Douglas ^a   Singh, Suraj P ^a   Franczak, Malgorzata B ^a   Goveas, Joseph S ^a   Li, Shi Jiang ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Alzheimer's disease; APOE4; Apolipoprotein E 4; Caudate nucleus; Hippocampus; Memory network; Papez circuit; Resting state functional connectivity; Thalamus

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; BASAL GANGLION; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CINGULATE GYRUS; COGNITION; CONNECTOME; CONTROLLED STUDY; EPISODIC MEMORY; FEMALE; FRONTAL GYRUS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; FUSIFORM GYRUS; HETEROZYGOTE; HIGH RISK POPULATION; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; INFERIOR FRONTAL GYRUS; INSULA; LEARNING; LIMBIC CORTEX; MALE; MEMORY; MENTAL PERFORMANCE; MIDDLE AGED; MIDDLE FRONTAL GYRUS; MIDDLE TEMPORAL GYRUS; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARAHIPPOCAMPAL GYRUS; PARIETAL CORTEX; POSTERIOR CINGULATE; PREFRONTAL CORTEX; RESTING STATE NETWORK; RISK ASSESSMENT; SUBCORTEX; SUPERIOR FRONTAL GYRUS; THALAMUS; BRAIN; BRAIN MAPPING; METABOLISM; NERVE CELL NETWORK; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; BRAIN; BRAIN MAPPING; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; NERVE NET; NEUROPSYCHOLOGICAL TESTS;

EID: 84901807675     PISSN: 00109452     EISSN: 19738102     Source Type: Journal    
DOI: 10.1016/j.cortex.2014.04.006     Document Type: Article

References (59)

1. Adamson M.M., Hutchinson J.B., Shelton A.L., Wagner A.D., Taylor J.L. Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE varepsilon4 allele. Neuropsychologia 2011, 49(9):2448-2455.
2. Aggleton J.P., Brown M.W. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. The Behavioral and Brain Sciences 1999, 22(3):425-444. discussion 444-489.
3. Allen G., Barnard H., McColl R., Hester A.L., Fields J.A., Weiner M.F., et al. Reduced hippocampal functional connectivity in Alzheimer disease. Archives of Neurology 2007, 64(10):1482-1487.
4. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage 2007, 38(1):95-113.
5. Atallah H.E., Frank M.J., O'Reilly R.C. Hippocampus, cortex, and basal ganglia: insights from computational models of complementary learning systems. Neurobiology of Learning and Memory 2004, 82(3):253-267.
6. Attems J., Yamaguchi H., Saido T.C., Thal D.R. Capillary CAA and perivascular Abeta-deposition: two distinct features of Alzheimer's disease pathology. Journal of Neurological Sciences 2010, 299(1-2):155-162.
7. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., et al. Patterns of brain activation in people at risk for Alzheimer's disease. The New England Journal of Medicine 2000, 343(7):450-456.
8. Callen D.J., Black S.E., Gao F., Caldwell C.B., Szalai J.P. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 2001, 57(9):1669-1674.
9. Caselli R.J., Dueck A.C., Locke D.E., Sabbagh M.N., Ahern G.L., Rapcsak S.Z., et al. Cerebrovascular risk factors and preclinical memory decline in healthy APOE epsilon4 homozygotes. Neurology 2011, 76(12):1078-1084.
10. Chen G., Ward B.D., Xie C., Li W., Wu Z., Jones J.L., et al. Classification of Alzheimer disease, mild cognitive impairment, and normal cognitive status with large-scale network analysis based on resting-state functional MR imaging. Radiology 2011, 259(1):213-221.
11. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261(5123):921-923.
12. Crivello F., Lemaitre H., Dufouil C., Grassiot B., Delcroix N., Tzourio-Mazoyer N., et al. Effects of ApoE-epsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons. NeuroImage 2010, 53(3):1064-1069.
13. Dennis N.A., Browndyke J.N., Stokes J., Need A., Burke J.R., Welsh-Bohmer K.A., et al. Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2010, 6(4):303-311.
14. Drzezga A., Becker J.A., Van Dijk K.R., Sreenivasan A., Talukdar T., Sullivan C., et al. Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain 2011, 134(Pt 6):1635-1646.
15. Filippini N., MacIntosh B.J., Hough M.G., Goodwin G.M., Frisoni G.B., Smith S.M., et al. Distinct patterns of brain activity in young carriers of the APOE- 4 allele. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(17):7209-7214.
16. Fleisher A.S., Sherzai A., Taylor C., Langbaum J.B., Chen K., Buxton R.B. Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups. NeuroImage 2009, 47(4):1678-1690.
17. Fox M.D., Raichle M.E. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nature Reviews Neuroscience 2007, 8(9):700-711.
18. Fox M.D., Zhang D., Snyder A.Z., Raichle M.E. The global signal and observed anticorrelated resting state brain networks. Journal of Neurophysiology 2009, 101(6):3270-3283.
19. Goveas J.S., Xie C., Chen G., Li W., Ward B.D., Franczak M.B., et al. Functional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adults. PLoS One 2013, 8(2):e55902.
20. Goveas J.S., Xie C., Ward B.D., Wu Z., Li W., Franczak M., et al. Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer's disease patients treated with donepezil assessed by resting-state fMRI. Journal of Magnetic Resonance Imaging 2011, 34(4):764-773.
21. Greicius M.D., Srivastava G., Reiss A.L., Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(13):4637-4642.
22. Haase L., Wang M., Green E., Murphy C. Functional connectivity during recognition memory in individuals genetically at risk for Alzheimer's disease. Human Brain Mapping 2011, 34(3):530-542.
23. Hedden T., Van Dijk K.R., Becker J.A., Mehta A., Sperling R.A., Johnson K.A., et al. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. Journal of Neuroscience 2009, 29(40):12686-12694.
24. Hornberger M., Wong S., Tan R., Irish M., Piguet O., Kril J., et al. Invivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease. Brain 2012, 135(Pt 10):3015-3025.
25. Jacobs D.M., Sano M., Dooneief G., Marder K., Bell K.L., Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995, 45(5):957-962.
26. Jicha G.A., Carr S.A. Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease. Journal of Alzheimers Disease 2010, 19(1):253-272.
27. Jones B.F., Barnes J., Uylings H.B., Fox N.C., Frost C., Witter M.P., et al. Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. Cerebral Cortex 2006, 16(12):1701-1708.
28. Konrad C., Ukas T., Nebel C., Arolt V., Toga A.W., Narr K.L. Defining the human hippocampus in cerebral magnetic resonance images - an overview of current segmentation protocols. NeuroImage 2009, 47(4):1185-1195.
29. Li S.J., Li Z., Wu G., Zhang M.J., Franczak M., Antuono P.G. Alzheimer disease: evaluation of a functional MR imaging index as a marker. Radiology 2002, 225(1):253-259.
30. Lind J., Persson J., Ingvar M., Larsson A., Cruts M., Van Broeckhoven C., et al. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain 2006, 129(Pt 5):1240-1248.
31. Machulda M.M., Jones D.T., Vemuri P., McDade E., Avula R., Przybelski S., et al. Effect of APOE epsilon4 status on intrinsic network connectivity in cognitively normal elderly subjects. Archives of Neurology 2011, 68(9):1131-1136.
32. Machulda M.M., Senjem M.L., Weigand S.D., Smith G.E., Ivnik R.J., Boeve B.F., et al. Functional magnetic resonance imaging changes in amnestic and nonamnestic mild cognitive impairment during encoding and recognition tasks. Journal of the International Neuropsychological Society 2009, 15(3):372-382.
33. Madsen S.K., Ho A.J., Hua X., Saharan P.S., Toga A.W., Jack C.R., et al. 3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects. Neurobiology of Aging 2010, 31(8):1312-1325.
34. Mayeux R., Saunders A.M., Shea S., Mirra S., Evans D., Roses A.D., et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med 1998, 338(8):506-511.
35. Mechelli A., Price C.J., Friston K.J., Ashburner J. Voxel-based morphometry of the human brain: methods and applications. Current Medical Imaging Reviews 2005, 1(2):105-113.
36. Meyer M.R., Tschanz J.T., Norton M.C., Welsh-Bohmer K.A., Steffens D.C., Wyse B.W., et al. APOE genotype predicts when-not whether-one is predisposed to develop Alzheimer disease. Nature Genetics 1998, 19(4):321-322.
37. Nicoll J.A., McCarron M.O. APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage. Amyloid: The International Journal of Experimental and Clinical Investigation: The Official Journal of the International Society of Amyloidosis 2001, 8(Suppl 1):51-55.
38. Papez J.W. A proposed mechanism of emotion. Archives of Neurology and Psychiatry 1937, 38(4):725-743.
39. Pievani M., Galluzzi S., Thompson P.M., Rasser P.E., Bonetti M., Frisoni G.B. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease. NeuroImage 2011, 55(3):909-919.
40. Reiter K., Alpert K.I., Cobia D.J., Kwasny M.J., Morris J.C., Csernansky J.C., et al. Cognitively normal individuals with AD parents may be at risk for developing aging-related cortical thinning patterns characteristic of AD. NeuroImage 2012, 61(3):525-532.
41. Rombouts S.A., Stam C.J., Kuijer J.P., Scheltens P., Barkhof F. Identifying confounds to increase specificity during a "no task condition". Evidence for hippocampal connectivity using fMRI. NeuroImage 2003, 20(2):1236-1245.
42. Ryan N.S., Keihaninejad S., Shakespeare T.J., Lehmann M., Crutch S.J., Malone I.B., et al. Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease. Brain 2013, 136(Pt 5):1399-1414.
43. Scarmeas N., Stern Y. Imaging studies and APOE genotype in persons at risk for Alzheimer's disease. Current Psychiatry Reports 2006, 8(1):11-17.
44. Sheline Y.I., Morris J.C., Snyder A.Z., Price J.L., Yan Z., D'Angelo G., et al. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42. The Journal of Neuroscience 2010, 30(50):17035-17040.
45. Sheline Y.I., Raichle M.E., Snyder A.Z., Morris J.C., Head D., Wang S., et al. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biological Psychiatry 2010, 67(6):584-587.
46. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(11):6037-6042.
47. Smith A.D. Imaging the progression of Alzheimer pathology through the brain. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(7):4135-4137.
48. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277(10):813-817.
49. Thal D.R., Capetillo-Zarate E., Larionov S., Staufenbiel M., Zurbruegg S., Beckmann N. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances. Neurobiology of Aging 2009, 30(12):1936-1948.
50. Verghese P.B., Castellano J.M., Holtzman D.M. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurology 2011, 10(3):241-252.
51. Villain N., Desgranges B., Viader F., de la Sayette V., Mezenge F., Landeau B., et al. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. The Journal of Neuroscience 2008, 28(24):6174-6181.
52. Vincent J.L., Kahn I., Snyder A.Z., Raichle M.E., Buckner R.L. Evidence for a frontoparietal control system revealed by intrinsic functional connectivity. Journal of Neurophysiology 2008, 100(6):3328-3342.
53. Vincent J.L., Snyder A.Z., Fox M.D., Shannon B.J., Andrews J.R., Raichle M.E., et al. Coherent spontaneous activity identifies a hippocampal-parietal memory network. Journal of Neurophysiology 2006, 96(6):3517-3531.
54. Wang L., Zang Y., He Y., Liang M., Zhang X., Tian L., et al. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. NeuroImage 2006, 31(2):496-504.
55. Welsh K., Butters N., Hughes J., Mohs R., Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Archives of Neurology 1991, 48(3):278-281.
56. Westlye E.T., Lundervold A., Rootwelt H., Lundervold A.J., Westlye L.T. Increased hippocampal default mode synchronization during rest in middle-aged and elderly APOE epsilon4 carriers: relationships with memory performance. The Journal of Neuroscience 2011, 31(21):7775-7783.
57. Xu Y., Xu G., Wu G., Antuono P., Rowe D.B., Li S.J. The phase shift index for marking functional asynchrony in Alzheimer's disease patients using fMRI. Magnetic Resononace Imaging 2008, 26(3):379-392.
58. Yip A.G., McKee A.C., Green R.C., Wells J., Young H., Cupples L.A., et al. APOE, vascular pathology, and the AD brain. Neurology 2005, 65(2):259-265.
59. Zarei M., Patenaude B., Damoiseaux J., Morgese C., Smith S., Matthews P.M., et al. Combining shape and connectivity analysis: an MRI study of thalamic degeneration in Alzheimer's disease. NeuroImage 2010, 49(1):1-8.